Javascript must be enabled to continue!
Efficacy of oral appliance therapy in patients following uvulopalatopharyngoplasty failure
View through CrossRef
ObjectiveUvulopalatopharyngoplasty (UPPP) is the most common surgical procedure performed to treat obstructive sleep apnea (OSA). This surgery, when performed alone, benefits only a minority of patients. This study was undertaken to determine the efficacy of oral appliance (OA) therapy following unsuccessful UPPP and assess for specific patient and polysomnographic characteristics that may identify those patients most likely to benefit from this combined treatment strategy.Study DesignRetrospective of clinical outcomes in patients undergoing UPPP followed by treatment with an OA.MethodsPolysomnographic results (baseline, status post‐UPPP, and status post‐UPPP with oral appliance use), age, gender, race, and body mass index were subjected to statistical analysis.ResultsThe mean apnea hypopnea index (AHI) decreased from 23.6 at baseline to 8.6 following UPPP and oral appliance therapy. The mean O2 nadir increased from 83% at baseline to 89.9% following UPPP and treatment with an oral appliance. Fifty percent of patients (9/18) achieved an AHI <5 and were deemed “cured” of their disease. Seventy‐three percent of patients (13/18) achieved benefit with an AHI <20 and ≥50% reduction in their baseline AHI, deemed “successful therapy.” No statistically relevant demographic or polysomnographic differences were found between those who were “cured” and those with persistent disease with the exception that the O2 nadir status post UPPP was found to be lower in the “cured” group.ConclusionOral appliance therapy is an effective treatment option for the majority of patients who have persistent obstructive sleep apnea following unsuccessful UPPP.Level of Evidence4
Title: Efficacy of oral appliance therapy in patients following uvulopalatopharyngoplasty failure
Description:
ObjectiveUvulopalatopharyngoplasty (UPPP) is the most common surgical procedure performed to treat obstructive sleep apnea (OSA).
This surgery, when performed alone, benefits only a minority of patients.
This study was undertaken to determine the efficacy of oral appliance (OA) therapy following unsuccessful UPPP and assess for specific patient and polysomnographic characteristics that may identify those patients most likely to benefit from this combined treatment strategy.
Study DesignRetrospective of clinical outcomes in patients undergoing UPPP followed by treatment with an OA.
MethodsPolysomnographic results (baseline, status post‐UPPP, and status post‐UPPP with oral appliance use), age, gender, race, and body mass index were subjected to statistical analysis.
ResultsThe mean apnea hypopnea index (AHI) decreased from 23.
6 at baseline to 8.
6 following UPPP and oral appliance therapy.
The mean O2 nadir increased from 83% at baseline to 89.
9% following UPPP and treatment with an oral appliance.
Fifty percent of patients (9/18) achieved an AHI <5 and were deemed “cured” of their disease.
Seventy‐three percent of patients (13/18) achieved benefit with an AHI <20 and ≥50% reduction in their baseline AHI, deemed “successful therapy.
” No statistically relevant demographic or polysomnographic differences were found between those who were “cured” and those with persistent disease with the exception that the O2 nadir status post UPPP was found to be lower in the “cured” group.
ConclusionOral appliance therapy is an effective treatment option for the majority of patients who have persistent obstructive sleep apnea following unsuccessful UPPP.
Level of Evidence4.
Related Results
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Pembrolizumab and Sarcoma: A meta-analysis
Pembrolizumab and Sarcoma: A meta-analysis
Abstract
Introduction: Pembrolizumab is a monoclonal antibody that promotes antitumor immunity. This study presents a systematic review and meta-analysis of the efficacy and safety...
4.N. Workshop: Maternal Oral Health Models and Initiatives in Global and Public Health Perspectives
4.N. Workshop: Maternal Oral Health Models and Initiatives in Global and Public Health Perspectives
Abstract
Achieving and maintaining good oral health is essential for both the oral and overall health of expecting mothers and...
Oral Manifestation of Sexual Transmitted Diseases
Oral Manifestation of Sexual Transmitted Diseases
Abstract: Sexually transmitted diseases (STDs) are transmitted through sexual contact, and can manifest in the oral cavity. This study aimed to determine the oral manifestations of...
The symptom network of oral health conditions in older populations with oral frailty: a cross-sectional study
The symptom network of oral health conditions in older populations with oral frailty: a cross-sectional study
Abstract
Background
Population aging is increasing globally, with oral frailty affecting 24% of the older population. Previous studies have demon...
The Impact of IL28B Gene Polymorphisms on Drug Responses
The Impact of IL28B Gene Polymorphisms on Drug Responses
To achieve high therapeutic efficacy in the patient, information on pharmacokinetics, pharmacodynamics, and pharmacogenetics is required. With the development of science and techno...
DENTAL STATUS OF PRESCHOOL CHILDREN WITH MOUTH BREATHING
DENTAL STATUS OF PRESCHOOL CHILDREN WITH MOUTH BREATHING
There is an increase in the number of children who have complicated nose breathing and its oral type. Preschool children are of particular concern according to clinicians. These ci...
Research on Financial Analysis and Evaluation
Research on Financial Analysis and Evaluation
In recent years, due to the impact of the new crown pneumonia epidemic, the economic development of countries around the world has been slow or even stagnant, and the same is true ...

